Gas chromatography–combustion–isotope ratio mass spectrometry analysis of 19-norsteroids: application to the detection of a nandrolone metabolite in urine

https://doi.org/10.1016/S0378-4347(01)00241-9Get rights and content

Abstract

Determination of whether the major metabolite of nandrolone in urine, 19-norandrosterone (19-NA), is exogenous or endogenous in origin is one of the most exciting challenges for antidoping laboratories. Gas chromatography–combustion–isotope ratio mass spectrometry (GC–C–IRMS) can be used to differentiate these two origins by carbon isotopic ratio analysis. A complete method for purification of 19-NA in urine has been established. Acetylated ketosteroids, and in particular 19-NA, are isolated from the urine matrix before analysis after hydrolysis and purification of urine by reversed-phase and normal solid-phase extraction. The limit of detection for 19-NA was about 60 ng with recoveries of 54–60%. Evidence of exogenous administration of 19-NA may be established from isotope ratio determination from the 13C/12C ratios of several synthetic 19-norsteroids compared to those obtained for endogenous steroids.

Introduction

The International Olympic Committee (IOC) first prohibited anabolic androgenic steroids for the Montreal Olympic games in 1976. Nandrolone or 19-nortestosterone (19-NT) belongs to this class of compounds and is one of the most widely used anabolic steroids. Administration of Nandrolone (or other 19-nonsteroid precursors such as norandrostendione or norandrostendiol) can be detected in urine from the presence of their two major glucuronic metabolites, 19-norandrosterone (19-NA) and 19-noretiocholanolone (19-NE) [1], [2] (Fig. 1). Other metabolites have been described but are presented in urine in smaller amounts [3]. By the IOC anti-doping code, an adverse report will be issued and may lead to sanction if a concentration of at least one metabolite in excess of 2 ng/ml or 5 ng/ml of urine is found in a male or female competitor, respectively. This threshold has been established in males in order to exclude low endogenous production of 19-NA which is well known in stallions [4] and boars [5], [6]. Different authors have recently reported such natural production in human beings [7], [8], [9], [10], [11]. No evidence of endogenous production of 19-NA producing a level of >2 ng/ml was found in males in these previous studies. The problem is more complex for females as nandrolone has been found in human ovarian follicular fluid [12] and in the placenta during pregnancy [13]. Mareck-Engelke et al. [14] reported that the concentration of 19-NA may reach 20 ng/ml in urine during pregnancy. These cases are, however, unusual in the context of anti-doping testing and are easily detected by a test for HCG. It has also been reported that some certain norsteroid (e.g. norethisterone) contained in contraceptive pills can be metabolised to 19-NA and 19-NE. In these cases, however, other relevant metabolites (tetrahydro-metabolites of norethisterone) are also present in urine.

Various sources of contamination have also been put forward in order to explain the presence of 19-NA in the urine of sports players who have claimed to be innocent. Food contaminated by endogenous production of 19-NA [15] or by exogenous administration of nandrolone used as a growth promoter animals [16] has been investigated, as have permitted nutritional supplements which contain ‘unexpected’ traces of anabolic steroid. In this context, differentiation between 19-NA in urine of endogenous and exogenous origin represents an important challenge for anti-doping laboratories. Since the introduction of gas chromatography–combustion–isotope ratio mass spectrometry (GC–C–IRMS) into the field of anti-doping testing, a similar problem which arises with testosterone abuse is in the process of being resolved. It has been shown that exogenous administration of testosterone can be differentiated from naturally high production by measuring the 13C/12C ratio [17], [18], [19], [20], [21], [22], [23]. Discrimination is made from the lower level of the 13C stable isotope in the source material used in the chemical synthesis of testosterone compared to endogenous testosterone production. Such differentiation between synthetic and endogenous origins has also been reported for other hormones such as DHEA [24] and corticosteroids [25], [26]. This report presents the first results of 13C/12C ratio measurement in 19-norsteroids. We describe a purification procedure for 19-NA in urine for use in GC–C–IRMS analysis and discuss the reliability of carbon isotope results obtained by GC–C–IRMS.

Section snippets

Chemicals and reagents

All the solvents and reagents were analytical grade purity (SDS, Villeurbanne, France; Carlo Erba, Val de Reuil, France; Merck, Darmstadt, Germany; Sigma, Saint Quentin, Fallavier, France).

Escherichia coli β-glucuronidase was supplied by Roche Molecular Diagnostic.

The synthetic reference codes were: 19-norandrosterone or 5α-estran-3α-ol-17-one (Promochem, Molsheim, France, ref. E-910), 19-noretiocholanolone or 5β-estran-3β-ol-17-one (Promochem, ref. 908), nandrolone or 19-nortestosterone

IAC extraction

In order to test the selectivity of the IAC, different fractions were collected during the different steps of the chromatography (loading, washing and elution). Large amount of 19-NA and 19-NE were found in the first two fractions (loading and washing) with the final yield in the eluted fraction was only 17% for 19-NA and 3% of the 19-NE. These results have been confirmed using two other gels obtained from the same supplier. These yields are insufficient for our purposes and do not corroborate

Conclusion

The method described here offers considerable potential to resolve cases of suspected nandrolone doping. At this time however, analytical limitations restrict its field of application to ‘high’ concentration of 19-NA in urine (over 60 ng/ml). Recent cases in antidoping testing have shown that even at these concentrations (more than 50 ng/ml) athletes and lawyers use the hypothesis of high endogenous levels of production to refute doping accusations. IRMS methodology can be of considerable

References (31)

  • L.L. Engel et al.

    Biol. Chem.

    (1958)
  • A.F. Rizzo et al.

    Anal. Chim. Acta

    (1993)
  • B. Lebizec et al.

    J. Chromatogr. B

    (1999)
  • L. Dehennin et al.

    J. Steroid Biochem.

    (1987)
  • G. Debruyckere et al.

    Anal. Chim. Acta

    (1993)
  • R. Aguilera et al.

    J. Chromatogr. B

    (1996)
  • R. Aguilera et al.

    J. Chromatogr. B

    (1999)
  • R. Aguilera et al.

    J. Chromatogr. B

    (1997)
  • B. Le Bizec et al.

    Anal. Chim. Acta

    (1993)
  • L. Dehennin et al.

    J. Chromatogr. B

    (1996)
  • R. Massé et al.

    Biomed. Mass Spectrom.

    (1985)
  • V.P. Uralets et al.
  • E. Benoit et al.

    Ann. Rech. Vet.

    (1985)
  • G. Maghuin-Rogister et al.

    Ann. Med. Vet.

    (1988)
  • M. Ciardi et al.
  • Cited by (30)

    • Analytical approach for the determination of steroid profile of humans by gas chromatography isotope ratio mass spectrometry aimed at distinguishing between endogenous and exogenous steroids

      2015, Journal of Pharmaceutical and Biomedical Analysis
      Citation Excerpt :

      According to the literature, the SPE was performed on octadecyl sorbent (C18), followed by the use of methanol [6–12], isopropanol [13], ethyl acetate or acetonitryl [14–17] for elution. Enzymatic hydrolysis was performed with β-glucuronidase—Escherichia coli [6–8,12,13] or Helix pomatia [16]. For the liquid extraction, diethyl ether [14,18] or methyl tert-buthyl ether [19–21] were used.

    • Use of isotope ratio mass spectrometry to differentiate between endogenous steroids and synthetic homologues in cattle: A review

      2013, Analytica Chimica Acta
      Citation Excerpt :

      The IRMS instrument has a linear range of measurement which is defined by the manufacturer. For a classical type instrument, δ13C value measurements with signal intensities between 1 and 10 nA at m/z 44 are considered reliable [50,92,93], or values above 0.8 mV [94] depending on the type of instrument. Before every injection series, the linear performance of the IRMS apparatus is verified by introducing a series of CO2 pulses with rising intensities.

    • A simplified procedure for GC/C/IRMS analysis of underivatized 19-norandrosterone in urine following HPLC purification

      2011, Steroids
      Citation Excerpt :

      The analysis by GC/C/IRMS requires an adequate sample pretreatment to avoid potential interferences. Different exhaustive approaches for sample pretreatment for 19-NA based on immunoaffinity chromatography (IAC) [24], combined solid phase extraction [25] or combined double liquid chromatography [26,27] have been published. Furthermore, to improve the thermal stability and to increase the volatility of the target compounds, as to improve their GC profile, chemical derivatization on the preconcentrated and purified urine extracts is often performed, resulting in an additional step prior to the GC/C/IRMS analysis (Table 1).

    View all citing articles on Scopus
    View full text